Methodology and application of adaptive and sequential approaches in contemporary clinical trials (Q1929694): Difference between revisions

From MaRDI portal
Created claim: Wikidata QID (P12): Q58910970, #quickstatements; #temporary_batch_1706335038149
ReferenceBot (talk | contribs)
Changed an Item
 
(4 intermediate revisions by 4 users not shown)
Property / describes a project that uses
 
Property / describes a project that uses: BayesDA / rank
 
Normal rank
Property / MaRDI profile type
 
Property / MaRDI profile type: MaRDI publication profile / rank
 
Normal rank
Property / full work available at URL
 
Property / full work available at URL: https://doi.org/10.1155/2012/527351 / rank
 
Normal rank
Property / OpenAlex ID
 
Property / OpenAlex ID: W2006128945 / rank
 
Normal rank
Property / cites work
 
Property / cites work: Statistical properties of the traditional algorithm-based designs for phase I cancer clinical trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Design and Analysis of Phase I Clinical Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer / rank
 
Normal rank
Property / cites work
 
Property / cites work: Optimal Bayesian-feasible dose escalation for cancer phase I trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Dose finding with escalation with overdose control (EWOC) in cancer clinical trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: One-Sample Multiple Testing Procedure for Phase II Clinical Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Designs for Group Sequential Phase II Clinical Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: A review of phase 2-3 clinical trial designs / rank
 
Normal rank
Property / cites work
 
Property / cites work: Seamlessly Expanding a Randomized Phase II Trial to Phase III / rank
 
Normal rank
Property / cites work
 
Property / cites work: Q4264744 / rank
 
Normal rank
Property / cites work
 
Property / cites work: Q4363933 / rank
 
Normal rank
Property / cites work
 
Property / cites work: One-Sided Sequential Stopping Boundaries for Clinical Trials: A Decision- Theoretic Approach / rank
 
Normal rank
Property / cites work
 
Property / cites work: An improved method for deriving optimal one-sided group sequential tests / rank
 
Normal rank
Property / cites work
 
Property / cites work: A Sample-Size-Optimal Bayesian Procedure for Sequential Pharmaceutical Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Optimal asymmetric one-sided group sequential tests / rank
 
Normal rank
Property / cites work
 
Property / cites work: Q4704712 / rank
 
Normal rank
Property / cites work
 
Property / cites work: Modification of Sample Size in Group Sequential Clinical Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Designed Extension of Studies Based on Conditional Power / rank
 
Normal rank
links / mardi / namelinks / mardi / name
 

Latest revision as of 02:27, 6 July 2024

scientific article
Language Label Description Also known as
English
Methodology and application of adaptive and sequential approaches in contemporary clinical trials
scientific article

    Statements

    Methodology and application of adaptive and sequential approaches in contemporary clinical trials (English)
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    9 January 2013
    0 references
    Summary: The clinical trial, a prospective study to evaluate the effect of interventions in humans under prespecified conditions, is a standard and integral part of modern medicine. Many adaptive and sequential approaches have been proposed for use in clinical trials to allow adaptations or modifications to aspects of a trial after its initiation without undermining the validity and integrity of the trial. The application of adaptive and sequential methods in clinical trials has significantly improved the flexibility, efficiency, therapeutic effect, and validity of trials. To further advance the performance of clinical trials and convey the progress of research on adaptive and sequential methods in clinical trial design, we review significant research that has explored novel adaptive and sequential approaches and their applications in Phase I, II, and III clinical trials and discuss future directions in this field of research.
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references